Uncovering the roots of Parkinson's disease, together
A global research initiative
Aligning Science Across Parkinson’s (ASAP) is fostering collaboration and resources to better understand the underlying causes of Parkinson’s disease. With scale, transparency, and open access data sharing, we believe we can accelerate the pace of discovery, and inform the path to a cure.
ASAP is now accepting Letters of Intent for the Collaborative Research Network 2025 Technical Track. This call will focus on supporting the development of novel, sustainable tools to accelerate validation and therapeutic R&D for emerging targets identified through ASAP discoveries. Awarded teams will receive funding of up to $2M per year for three years.
As we wrap up 2024, we are excited to share how we pushed the Parkinson’s disease research field forward. Together, our supported programs worked to funnel new ideas into Parkinson’s disease R&D, facilitate the rapid exchange of ideas, ensure researchers can build upon ASAP-funded work, and establish a diverse pipeline for the next generation of researchers.
GP2 announced the 9th data release on the Terra and the Verily® Workbench platforms in collaboration with AMP® PD. This release includes 17,690 additional genotyped participants.
Latest News
Investing in Open Science: Key Considerations for Funders
ASAP program officer, Dana Lewis, PhD, joins Preprints in Motion to discuss our open science preprint that covers costs associated with open science policies from a funder’s perspective.
Advancing Parkinson’s Disease Research: APDA’s Commitment to Innovation
The American Parkinson Disease Association (APDA) highlights Dr. Roberta Marongiu from CRN Team Kaplitt for her work exploring the role of biological sex in Parkinson’s disease.
Immune cells may lead to more Parkinson’s cases in men
New research from Team Sulzer reveals how a protein in brain cells may drive Parkinson’s onset—and offers a possible explanation for why Parkinson’s is much more common in men.
